The Effect of Mirikizumab on Fecal Calprotectin and C-Reactive Protein in Phase 3 Studies of Patients With Moderately-To-Severely Active Ulcerative Colitis
AuthID
P-00Y-1PA
P-00Y-1PA
© 2024 CRACS & Inesc TEC - All Rights Reserved Política de Privacidade | Terms of Service